ÂÜÀòÂÒÂ×

Mark G. Walin has extensive experience in business development, marketing, and sales, with their most recent role being the Senior Vice President of Business Development and Marketing at BIO-CAT since December 2020. Prior to that, they held the same position at BIO-CAT Enzymes since September 2016. Mark also served as the Chief Commercial Officer at Nuvoflex from July 2016, where they were responsible for post-FDA approval commercialization of medical device technologies. Before that, they worked at Perrigo from October 2009 to September 2016, initially as the Vice President of Sales and later as the Vice President of Sales, North America at PBM Products LLC, a Perrigo Company. Mark's early career includes roles as the National Director of Sales at Abbott Diabetes Care from February 2006 to October 2009, and as the Director of Sales & Marketing at Abbott Nutrition from January 1989 to January 2006.

Mark G. Walin graduated from the University of South Florida in 1986, where they received a degree in Social/Behavioral Science with a focus on Business. Mark G. also pursued Executive Education at the University of Chicago, although specific dates and degree information were not provided.